GlaxoSmithKline is to scrap individual sales targets for its commercial staff as it seeks to repair its image and reform working practices after allegations in China that its staff paid officials up to $500m in bribes.
葛兰素史克(GlaxoSmithKline, GSK)将取缔针对商业部门员工的个人销售目标。在其manbetx3.0 员工被指向政府官员行贿高达5亿美元后，这家药业巨擘正寻求修复自身形象，改革工作方式。
您已阅读9%（310字），剩余91%（3269字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。